• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec30
Gilead Sciences CEO Daniel O'Day Selling Company Common Stock
21:23
Regeneron Initiates Phase III Clinical Trial for Birch Pollen-Related Eye Allergy Treatment
16:32
Simplify Asset Management Inc. Increased Holdings in Regeneron Pharmaceuticals
13:16
Dec29
United Therapeutics Corp Executives Report Common Stock Disposition
21:32
CFRA downgrades ALRAM's target price to $422
18:57
Dec28
Vontobel Holding Ltd. Increased Holdings in Natera, Inc. by 192.5% in Third Quarter
13:20